EP10.02: Thoracoamniotic shunts in isolated large macrocystic congenital cystic adenomatoid malformations.

This article discusses the effectiveness of thoracoamniotic shunts in treating large macrocystic congenital cystic adenomatoid malformations (CCAM) in fetuses. The study, conducted at a fetal therapy center between 2013 and 2023, involved 8 fetuses with severe mediastinal shift and hydrops. Shunt insertion successfully reduced the size of CCAM, corrected mediastinal shift, and resolved hydrops in all cases. The study reported a postnatal survival rate of 87.5%, with premature delivery being the main complication. Overall, fetal thoracoamniotic shunting appears to have favorable outcomes for large macrocystic CCAM. [Extracted from the article]